arteriovenous fistula
Conditions
Interventions
M-RADAR group:In the M-RADAR technique, a longitudinal skin incision was made near the vessels in the forearm. Subcutaneous adipose tissue was carefully separated using curved hemostatic forceps to ex
CT group:In the CT procedure, a longitudinal forearm incision was made. After adequate vein mobilization and devascularization, an end-to-side anastomosis was performed between the vein and artery usi
Sponsors
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-80 years, with no gender restrictions; (2) Diagnosis of end-stage renal disease and a preference for hemodialysis; (3) Initial arteriovenous fistula creation on the surgical side of the upper extremity, meeting vascular criteria outlined in Figure 3, including a patent return vein, a cephalic vein diameter >= 2 mm, a postoperative cannulation length of >=10 cm, radial artery diameter >= 1.5 mm, and a distance between the cephalic vein and radial artery not exceeding 2 cm on ultrasound, with no significant stenosis or calcification in the artery; (4) Expected survival duration >12 months; (5) Informed consent and willingness to participate in clinical follow-up.
Exclusion criteria
Exclusion criteria: (1) Those currently enrolled in another clinical trial involving drugs or medical devices; (2)Pregnant or breastfeeding women; (3) Patients with an ejection fraction (EF) <30% as assessed by echocardiography; (4) Patients with severe pathological changes in other organs, including the cardiovascular and cerebrovascular systems, within the past month. (5) Patients with a life expectancy of less than one year; (6) Patients with central venous lesions on the operative side, including a history of central venous catheterization, breast cancer surgery, cardiac pacemaker implantation, or other central venous ; (7) Patients diagnosed with severe infections; (8) Patients with arterial stenosis on the operative side.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Access primary patency;Incidence of stenosis at the anastomotic site; | — |
Secondary
| Measure | Time frame |
|---|---|
| Maturity rate;Access assisted primary patency;Access cumulative patency;Complications associated with AVF: infection, thrombosis, stenosis, steal syndrome;Time to first cannulation;Mortality rate;Hospitalization rate due to AVF-related complications; | — |
Countries
China
Contacts
Public ContactShi Yaxue
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Outcome results
None listed